NDC 54092-391 – Adderall XR

Dextroamphetamine Sulfate 7.5 mg/1; Dextroamphetamine Saccharate 7.5 mg/1; Amphetamine Aspartate Monohydrate 7.5 mg/1; Amphetamine Sulfate 7.5 mg/1 · Capsule, Extended Release · Oral

Human Prescription Drug DEA schedule CII

Product NDC54092-391

Product details

Brand name
Adderall XR
Generic name
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
Capsule, Extended Release
Route
Oral
Marketing category
NDA · NDA021303
Marketed since
October 11, 2001
Listing expires
December 31, 2027
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Adderall →

Package NDC codes (1)

Package NDCDescriptionSince
54092-391-01100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (54092-391-01)May 22, 2002

Other Adderall products